Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Homologous Species Neoplastic Antibodies

Abstract

Prehn and Main1, in a review of the subject, state that the demonstration of circulating cytotoxins is much simpler when heterologous tissue transplants are used as antigens than when homologous tissues are used. Schrek and Preston2, using the Bagg rat lymphosarcoma in Sprague–Dawley rats, report the successful demonstration of serum cytotoxins in the rats (25 per cent of the total) in which the tumour had regressed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Prehn, R. T., and Main, J. M., J. Nat. Cancer Inst., 14, 537 (1953).

    CAS  PubMed  Google Scholar 

  2. Schrek, Robert, and Preston, Frederick W., Surgical Forum of the American College of Surgeons (1954).

  3. Coriell, Lewis L., Tall, Milton G., and Gaskill, Helen, Science, 128, 198 (1958).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

CRANSTON, H., EGGERT, F. Homologous Species Neoplastic Antibodies. Nature 183, 1471–1472 (1959). https://doi.org/10.1038/1831471b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/1831471b0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing